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Introduction
Dynamic changes in oxygen demand can induce systemic al-
terations to the vasculature of organisms during development. 
In the embryonic eye, oxygen is delivered to ocular tissues 
through the hyaloidal vasculature, a transient network that is 
established during early optic cup stages and is important for 
the development of the lens, vitreous, and retina. The hyaloidal 
vasculature consists of different distinct anatomical structures, 
including the hyaloidal artery (HA), the vasa hyaloidea propria, 
and the tunica vasculosa lentis (Fig. 1 A). By the third trimester 
in humans and in postnatal 3–4-wk-old rodents, the hyaloidal 
network undergoes apoptosis and regresses (Ito and Yoshioka, 
1999;  Brown  et  al.,  2005).  Starting  at  birth  and  continuing 
through the first postnatal month, the neurosensory retina ma-
tures, and the adult retinal vasculature develops as three distinct 
vascular plexuses, each localized to a specific plane in the ret-
ina. The inner plexus appears first and is localized to the inner 
retina ganglion cell layer. The outer plexus forms at the outer 
edge of the inner nuclear layer, and, finally, an intermediate 
vascular plexus is formed at the inner edge of the inner nuclear 
layer. Importantly, the formation and maturation of the retinal 
vasculature occur concomitant with hyaloidal vessel regression 
in both humans and rodents, suggesting that the two processes 
may be intrinsically linked and regulated by oxygen availability 
(Fig. 1 B; Ye et al., 2009; Kurihara et al., 2010).
The precise mechanisms controlling hyaloidal vessel   
regression are not clear, but if the vessels do not completely   
regress in humans, persistent hyperplastic primary vitreous 
(PHPV; Reese, 1955; Goldberg, 1997) may occur and cause 
blindness in neonates. Several nonexclusive hypotheses of the 
vascular abnormalities observed in PHPV have been proposed, 
including the cessation of hyaloidal vascular blood flow (Lang   
et al., 1994; Meeson et al., 1996; Brown et al., 2005), accumula-
tion  of  antiangiogenic  factors  pooling  in  the  vitreous  (Preis   
et al., 1977; Lutty et al., 1983), or the production of cytokines 
from infiltrating macrophages that induce apoptosis in the   
endothelial cells (Lang and Bishop, 1993; Lang et al., 1994; 
Diez-Roux and Lang, 1997; Lobov et al., 2005; Albè et al., 2008). 
S
uccessful transition from embryonic to adult circu-
lation is critical for survival of mammalian organ-
isms. This shift occurs in the central cardiovascular 
circulation and in the eye as oxygen tension increases. 
However, its regulation is not well understood. We have 
used combinatorial gene deletion and overexpression   
assays to assess the effect of astrocyte-targeted deletion   
of von Hippel–Lindau tumor suppressor (Vhl), hypoxia- 
inducible factor-s (Hif-s), and Vegf on the normal   
regression of the hyaloidal vessels, the fetal ocular circula-
tion system. Astrocytic Vhl deletion induced accelerated 
hyaloidal regression and subsequent massive secondary 
outgrowth. Combinatorial gene deletion involving Vhl, 
Hif-s, and Vegf genes revealed that HIF-2/vascular   
endothelial growth factor signaling induces secondary 
outgrowth in Vhl mutants. Conversely, HIF-1 regulated 
macrophage migration inhibitory factor and promoted 
macrophage infiltration that accelerates hyaloidal ves-
sel regression. The phenotype observed in Vhl mutants 
strongly resembles human persistent hyperplastic primary 
vitreous cases and may provide insights into vascular   
remodeling mechanisms in other systems.
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Figure 1.  Development of in vivo hyaloidal vascular apoptosis assay system. (A) Vascular cast of a wild-type C57BL/6j P9 eye. Hyaloidal vasculature is 
colored according to the depth from the optic nerve head. TVL, tunica vasculosa lentis; VHP, vasa hyaloidea propria. (B) Schematic hyaloidal regression 
model. Note that the formation and maturation of the retinal vasculature on the astrocytes occur concomitant with hyaloidal vessel regression. (C and D) The 
progression and dynamics of hyaloidal vessel regression monitored in vivo using CSLO and ICG angiography. (C) Representative images of the regressing 
hyaloidal network from five different angles show central and peripheral vessels at various developmental stages in wild-type C57BL/6j mice. (D) Regres-
sion is quantified by counting the number of branching points of vessels derived from the central vessels. Values from key time points in hyaloidal vascular 
regression are plotted on a scatter plot as the number of branching points (y axis) at P11, 14, 21, 28, and 40 developmental stages (x axis; n = 6–8). 
Note that hyaloidal vessels are abundant and extensively branched at early stages but mostly absent by P40. Error bars indicate mean ± SD. (E) The daily 
regression of single vessels is shown over a 4-d span in a live animal. Arrows in each panel mark a vessel that is regressing; arrowheads label the space 
that the vessel occupied over the previous days. (F) TUNEL staining (top left) and DAPI counterstaining (top right) of the P6 hyaloidal network (merged in 
bottom left and right; marked by boxed area) marks entire vessels. Note that hyaloidal vascular regression visualized by in vivo imaging follows endothelial 
apoptosis. Bars: (C and E) 2,000 µm; (F) 1,000 µm.691 Astrocyte pVHL mediates vascular remodeling • Kurihara et al.
Results
Regression of the hyaloidal vasculature can 
be effectively monitored in vivo
Components of the hyaloidal vasculature including HA, vasa 
hyaloidea propria, and tunica vasculosa lentis in the vitreous 
cavity are the primary blood supply for the eye during em-
bryonic and early postnatal stages (Fig. 1 A). Previous studies 
have examined hyaloidal regression using sectioned or iso-
lated hyaloidal vasculature (Ito and Yoshioka, 1999; Kato   
et al., 2002; McKeller et al., 2002; Lobov et al., 2005). How-
ever, these techniques do not permit adequate visualization   
of the vascular network; vessels are fragile and may be lost 
during dissection, and their 3D relationships to each other 
and the posterior segment of the eye are not adequately visual-
ized. Therefore, we established a novel in vivo imaging tech-
nique that combines confocal-scanning laser ophthalmoscopy 
(CSLO) and indocyanine green (ICG) angiography. Using   
this system, we systematically monitored the regression of   
the hyaloidal vasculature across several developmental stages   
in vivo (Fig. 1 C). The number of branching points of the ves-
sels was also counted from these images to quantify the rate of   
regression (Figs. 1 D and S1). By postnatal day 28 (P28), the 
number of branching points of hyaloidal vessels was minimal, 
and few vessels were detectable by P40 (Fig. 1, C and D). 
These findings were consistent with data obtained from a pre-
vious study (Ito and Yoshioka, 1999), thus validating the use 
of this technique to monitor hyaloidal regression. By using 
this in vivo imaging technique, the dynamics of hyaloidal re-
gression can be monitored in real time, and rodents do not 
have to be sacrificed at each time point, thus maximizing the 
information obtained from each individual. In fact, we were 
able to monitor the loss of individual vessels over a 4-d span 
(Fig. 1 E). TUNEL positivity of intact vessels is also observed 
in stage P6 isolated hyaloidal vasculature (Fig. 1 F), implying 
that  the  apoptotic  stimulus  once  received  may  be  passed 
quickly through endothelial cells in intact vessels. Collec-
tively, these results demonstrate that in vivo CSLO and ICG 
angiography is an excellent system for examining the pro-
gression of hyaloidal regression.
Conditional deletion of Vhl in astrocytes 
results in accelerated primary hyaloidal 
vascular regression followed by massive 
secondary neovascularization
We previously reported persistent hyaloidal vasculature in post-
natal mouse eyes after conditional Vhl deletion in neural retinal 
cells (Kurihara et al., 2010). Because of their colocalization with 
retinal vessels (but not with the hyaloidal vasculature; Fig. S2) 
and known roles in angiogenesis, we hypothesized that pVHL/
HIF signaling in astrocytes may also play a critical role in 
hyaloidal  vascular  regression.  To  determine  the  function  of 
pVHL in hyaloidal vessel regression, we used a conditional de-
letion approach to inactivate Vhl using floxed alleles in glial 
fibrillary acidic protein (GFAP)–Cre mice (Fig. S3; Bajenaru 
et al., 2002). In these mice, recombination occurs in retinal 
astrocytes during neonatal stages (Weidemann et al., 2009, 2010).
Alternatively, mutations to the Arf tumor suppressor (p19
Arf) or 
downstream effector protein p53 may induce hyaloidal vessel 
persistence (McKeller et al., 2002). This is significant and may 
be relevant to PHPV because p53 functions as a tumor suppres-
sor by inducing apoptosis in response to stress, including hy-
poxia (Messmer-Blust et al., 2009). Additionally, Wnt/-catenin 
signaling has been shown to regulate hyaloidal vessel regression; 
Wnt7b released from macrophages associates with Frz4/Lrp5 
receptors and activates the canonical Wnt pathway to induce 
programmed cell death in hyaloidal endothelial cells (Kato   
et al., 2002; Xu et al., 2004; Lobov et al., 2005; Ye et al., 2009). 
In humans, mutations to Wnt7b, Frz4, or Lrp5 have been linked 
to familial exudative vitreoretinopathy and Norrie disease with 
PHPV. However, most cases of PHPV are unilateral and not linked 
to any specific genetic mutations (Reese, 1955; Goldberg, 1997). 
Hence, it is important to better understand mechanisms under-
lying the normal regression of the hyaloidal vasculature as well 
as those factors that contribute to abnormalities in this process.
During normoxia, von Hippel–Lindau protein (pVHL), a 
substrate recognition component of an E3-ubiquitin ligase, 
efficiently and rapidly destabilizes hypoxia-inducible factor 
(HIF)  subunits (e.g., HIF-1 and HIF-2). During hypoxia, 
HIF-s accumulate, translocate to the nucleus, and regulate 
the expression of HIF target genes that control diverse cellular 
processes such as glycolytic metabolism, cell proliferation, and 
angiogenesis (Maxwell et al., 1999). A requirement for HIF-1 
regulation  of  hyaloidal  regression  has  been  demonstrated  in 
transgenic mice. We have previously demonstrated persistence 
of hyaloidal vasculature after conditional inactivation of pVHL 
and resulting HIF hyperactivity in sensory retinal cells; further-
more, the vascular defects in these mice were rescued by delet-
ing Hif-1 or through local VEGF inhibition (Kurihara et al., 
2010). Persistent hyaloidal vasculature is also observed in Cbp/
p300-interacting  transactivator  with  Glu/Asp-rich  carboxy-
terminal domain 2 (Cited2
/) mice (Chen et al., 2008). Cited2 
is expressed in the embryonic lens and is a negative transcrip-
tional modulator of HIF-1. The conditional deletion of Hif-1 
in the lens of Cited2
/ mice rescues the vascular phenotype by 
limiting VEGF expression. Therefore, in the retina and lens, the 
oxygen-sensitive HIF-1 proteins function to promote angio-
genesis of the hyaloidal vasculature.
Retinal astrocytes colocalize with the inner layer of retinal 
blood vessels on the vitreal surface of the retina, making them 
ideal oxygen sensors during the neonatal period, during which 
the most dramatic vascular changes (e.g., hyaloidal regression 
and retinal vascular development) are occurring. In this study, 
we perform genetic gain- and loss-of-function assays of the 
pVHL/HIF signaling pathway in astrocytes. We also perform 
transplantation  assays  with  astrocytes  ectopically  expressing 
dominant-stable Hif-1 and Hif-2 genes to mimic a hypoxic 
response. Using these techniques, we show that HIF-1 and 
HIF-2 exert divergent regulatory functions during hyaloidal 
vessel regression. We present a model that may serve to alter 
prevailing concepts of how PHPV in humans progresses, thereby 
helping to develop more effective therapeutic interventions. In 
addition, we suggest that this work may serve as a model for 
macrophage-mediated vascular remodeling in other systems.JCB • VOLUME 195 • NUMBER 4 • 2011   692
that an increase in Vegf expression in the eye, secondary to Vhl 
deletion (Weidemann et al., 2010), might be responsible for 
inducing  the  secondary  outgrowth.  Similar  to  observations 
made in Vhl/Hif-2 double and Vhl/Hif-1/Hif-2 triple mu-
tants, the secondary outgrowth was not observed in Vhl/Vegf 
double mutants (Fig. 3 A). These data demonstrate that pVHL/
HIF-2/VEGF signaling is responsible for generating the out-
growth phenotype in Vhl mutants in late neonatal stages.
To determine the activity of HIFs in astrocytes at differ-
ent time points and to determine why the vessels initially   
regress at faster rates in younger Vhl mutant mice, we examined 
the phenotypes of Vhl mutants and the double or triple combi-
national mutants at P14. Significantly accelerated hyaloidal 
regression was observed in Vhl, Vhl/Hif-1, Vhl/Hif-2, or Vhl/
Vegf  double  mutants  compared  with  littermate  controls  but   
not in Vhl/Hif-1/Hif-2 triple mutants (P = 0.0025, 0.0033, 
0.015, and 0.032 for Vhl, Vhl/Hif-1, Vhl/Hif-2, and Vhl/Vegf, 
respectively; Fig. 3 B; quantified in Fig. 3, C–G). These find-
ings suggest that HIF-1 and HIF-2 function independently   
of VEGF to mediate the accelerated regression phenotype.
Collectively,  these  results  suggest  that  in  astrocytes, 
HIF-1 and HIF-2 may exert differential effects on hyaloidal 
vessel stability. Although HIF-2 appears to induce later-stage 
proangiogenic stabilization of the hyaloidal vessels (through 
VEGF up-regulation; Fig. 3 A), both HIF-1 and HIF-2 may 
induce events that lead to apoptosis in hyaloidal vessels. These 
findings are significant, as a role for HIF-1 in astrocytes has 
not been previously reported (Weidemann et al., 2009, 2010).
HIF-1 in astrocytes regulates macrophage 
infiltration by regulating expression  
of macrophage migration inhibitory  
factor (MIF)
MIF was first identified as a regulator of macrophage infiltra-
tion (Bloom and Bennett, 1966) and was shown to be a direct 
target  of  HIF-1  in  fibroblasts  under  hypoxic  conditions 
through interaction with a hypoxia response element on its   
promoter (Welford et al., 2006). Based on this, we decided   
to analyze the temporal and spatial changes in Mif expression   
in  wild-type  postnatal  developing  eyes  during  hyaloidal   
regression. Using real-time RT-PCR analyses of homogenized 
murine retinas, we observed a progressive reduction of Mif 
transcripts from P3 to 14 (at P14, its expression was signifi-
cantly down-regulated compared with P3 or 9 [P = 0.00025 or 
0.043, respectively]) before stabilization (Fig. 4 A). Impor-
tantly, this pattern is inversely correlated with known patterns 
of oxygen concentration in the inner retina (Yu and Cringle, 
2001; Kurihara et al., 2010) during hyaloidal regression and 
retinal vascular development on astrocytes. Using immunohisto-
chemistry, MIF was detected in GFAP-positive retinal astro-
cytes  at  multiple  time  points  (P14-staged  retina  is  shown   
in Fig. 4 B). Importantly, in Vhl/Hif-2 double mutants, in   
which  HIF-1  was  constitutively  activated  and  hyaloidal   
regression was  accelerated,  significantly  increased  expres-
sion of Mif mRNA was detected at P14 (P = 0.030; Fig. 4 C). 
Additionally, F4/80 (a macrophage-specific marker) expres-
sion was also twofold up-regulated (P = 0.043; Fig. 4 C).   
Using CSLO, we serially imaged the hyaloidal vessels 
from their entrance into the eye at the optic nerve to their ter-
minal tips on the posterior lens. We confirmed that the primary 
hyaloidal vascular stalk emerged from the optic nerve head and 
branched as it crossed the posterior vitreous cavity during the 
early postnatal period (Fig. 2 A). In control mice, the vessels 
branch frequently as they follow convoluted paths through the 
vitreous toward the peripheral regions of the lens (Fig. 2 A). 
Between P13 and 18, transgenic mice with Vhl mutations had 
significantly  accelerated  primary  hyaloidal  vessel  regression 
compared with littermate controls (P = 0.00066, 0.0098, and 
0.011 at P13, 15, and 18, respectively; Fig. 2 B). However, at 
P20, significantly more branching points of primary hyaloidal 
vessels were observed in the transgenic mice compared with 
littermate controls (P = 0.044; Fig. 2 B). Dense aggregates of 
vessels  coalescing  around  the  central  HA  were  observed  in 
deeper layers of the vitreous closer to the optic nerve head 
(Fig. 2 A). By P23, these aggregates of vessels were observed 
in the anterior vitreous near the lens, whereas few vessels are 
observed in littermate controls (Fig. 2 A). These vessels per-
sisted throughout the lives of the animals and were observed 
as late as P248 (Fig. 2 C), the longest that the transgenic mice 
were observed to survive. Retinal vascular defects were also 
observed; the transgenic mice had areas of massively diluted 
and highly branched vessels, changes that were not observed in 
littermate controls (Fig. S4; Weidemann et al., 2010). Addi-
tionally, an increase of astrocytic density was observed in Vhl 
mutants (Fig. S4). High-resolution CSLO (Fig. 2 D), histologi-
cal analysis (Fig. 2 E), optical coherence tomography (OCT; 
Fig. 2 F), and corrosion casts (Fig. 2 G) of the hyaloidal vas-
cular regrowth in transgenic animals demonstrated a clear 
connection  to  the  ophthalmical  artery  as  it  emerged  from   
the optic nerve head. These findings suggest that HA remains 
viable and can respond to proangiogenic cues during later 
postnatal stages. These data also clearly demonstrate a strict 
requirement for pVHL for the regulation of normal hyaloidal 
vessel regression and prevention of PHPV. Finally, as the ter-
minal features of this phenotype strongly resemble features 
of human cases of PHPV (Reese, 1955; Goldberg, 1997), the 
PHPV phenotype in humans may not simply be caused by 
failure of the primary hyaloidal vasculature to regress but 
may also be caused by secondary outgrowth of the primary 
hyaloidal vascular structures.
Conditional deletion strategies reveal 
divergent functions of Hif-1 or Hif-2 in 
retinal astrocytes
To more clearly understand the molecular mechanism of Vhl 
activity in astrocytes, we deleted it in combination with one   
or both of the downstream targets Hif-1 or Hif-2. In adult 
mice (P40), massive secondary outgrowth was observed in 
Vhl/Hif-1  double  mutants  but  not  in  Vhl/Hif-2  double   
mutants or Vhl/Hif-1/Hif-2 triple mutants (Fig. 3 A). These 
findings strongly suggest that the Hif-2 gene in astrocytes is 
primarily responsible for the persistence and outgrowth of the 
hyaloidal vessels. VEGF is a direct target of HIFs and a well-
characterized proangiogenic factor. Therefore, we hypothesized 693 Astrocyte pVHL mediates vascular remodeling • Kurihara et al.
Figure 2.  Development of persistent hyaloidal vasculature in Vhl;GFAP-Cre knockout (KO) mice. (A–C) The conditional deletion of Vhl in astrocytes 
using GFAP-Cre induces early accelerated regression of hyaloidal vessels followed by massive secondary outgrowth. (A) Representative in vivo images 
of hyaloidal vasculature in two different dimensional depth of Vhl mutants (third and fourth rows) and control littermates (first and second rows) from P7 
to 28. (B) Quantification of the primary (but not secondary outgrowth of) hyaloidal vasculature at P10, 13, 15, 18, and 20 on a scatter plot (n = 4–6). 
*, P < 0.05; **, P < 0.01. Error bars indicate mean ± SD. (C) Secondary outgrowth of hyaloidal vasculature observed at stage P248 (8 mo). Note 
that vessels form a stalk formation in the deep optical vitreal regions in early stages (fourth row in A). Significantly fewer branching point numbers of 
the primary hyaloidal vasculature were observed in Vhl mutants compared with controls during P13 to 18 stages (B). Pronounced secondary outgrowth 
from the stalk occurs from P20 and persists throughout the lives of the Vhl mutants (A and C). (D–G) Stalk formation observed in CSLO (D), paraffin-
embedded section (E), OCT (F), and in vascular casts (G). Note the connecting stalk (closed arrows) between the secondary outgrowth (open arrows) 
and the optic artery. Bars: (A, C, and D) 2,000 µm; (E and F) 200 µm.JCB • VOLUME 195 • NUMBER 4 • 2011   694
the  pVHL-binding  sequences  (P402A/P564A  and  P405A/ 
P531A, respectively; Yan et al., 2007). C8-D1A cells were   
cotransfected with Gfp to monitor transfection efficiency, 
and Hif-1  and  Hif-2  overexpression  was  confirmed  using   
RT-PCR  (Fig.  4  E).  The  effects  of  transfecting  CA–Hif-1  
and CA–Hif-2 in vitro were monitored using RT-PCR and quan-
titative  sandwich  ELISAs.  Vegf,  a  well-established  target  of 
HIFs, is significantly up-regulated after CA–Hif-2 transfection 
(P = 0.00024; Fig. 4 E). Increases in secreted VEGF protein were 
also observed (2.42-fold; P = 0.009; Fig. 4 F). These data are 
compatible with previous findings showing that HIF-2 (but not 
HIF-1)  in  astrocytes  is  responsible  for  regulating VEGF  or 
erythropoietin production in vivo during hypoxia or after Vhl  
deletion (Weidemann et al., 2009, 2010). Surprisingly, the trans-
fection  of  CA–Hif-1  induces  significant  Mif  up-regulation   
(P = 0.00057; Fig. 4 E) and 10.1-fold (P = 0.008) secreted protein 
production (Fig. 4 F); no difference in Mif mRNA and MIF 
protein induction by CA–Hif-2 is observed in Gfp-transfected 
controls (Fig. 4, E and F). There have been no previous reports of   
a gene being predominantly regulated by HIF-1 in astrocytes.
Similar changes were observed in Vhl mutants (P = 0.00035 
and 0.00044 for Mif and F4/80, respectively; Fig. S5 A) but 
not in Vhl/Hif-1 double mutants (Fig. S5 B). These data sug-
gest that constitutively active HIF-1 may activate Mif up-
regulation in Vhl mutants and induce infiltration of circulating 
macrophages,  leading  to  accelerated  hyaloidal  regression. 
This  is  significant  because  others  have  shown  that  macro-
phages  have  clear  functions  in  hyaloidal  vessel  regression 
(Lang and Bishop, 1993; Lobov et al., 2005), but the manner 
in which they are recruited is not clear.
To identify the molecular activities of HIF-1 in astro-
cytes,  we  performed  overexpression  assays  in  the  murine   
C8-D1A  astrocyte  line.  These  cells  exhibit  fibrous  astrocytic 
morphologies and express GFAP (Alliot and Pessac, 1984). 
Using immunohistochemistry, we detected robust levels of 
MIF in the cytoplasm of these cells (costaining with phalloi-
din  and  DAPI  mark  the  contours  and  nuclei  of  the  cells;   
Fig. 4 D). Constitutively active Hif-1 (CA–Hif-1) or Hif-2 
(CA–Hif-2) expression constructs were used; these constructs 
were generated using site-directed mutagenesis to remove 
Figure 3.  Secondary outgrowth but not accelerated hyaloidal 
regression in Vhl mutants is caused via the HIF-2/VEGF signaling 
pathway. (A) Secondary outgrowth in various combinations of 
astrocyte-specific knockout (KO) mice at P40. Note that massive 
secondary outgrowth is observed in Vhl (both HIF-1 and HIF-2 
are stabilized) and Vhl/Hif-1 double mutants (only HIF-2 is 
stabilized). The outgrowth phenotype is prevented in Vhl/Hif-2 
(only HIF-1 is stabilized), in Vhl/Hif-1/Hif-2, or in Vhl/Vegf 
mutants, demonstrating that HIF-2/VEGF signaling is required 
for the development of secondary outgrowth. (B–G) Represen-
tative hyaloidal vascular images (B) and numbers of branching 
points (C–G) in various combinations of knockout mice at P14   
(n = 4–8). Note that accelerated hyaloidal regression is observed 
in Vhl (C), Vhl/Hif-1 (D), VHL/Hif-2 (E), and Vhl/Vegf (G) but 
not Vhl/Hif-1/Hif-2 (F) mutants, demonstrating that HIF-1 and 
HIF-2 compensate for this phenotype independently from VEGF. 
n.s., not significant. *, P < 0.05; **, P < 0.01. Error bars indi-
cate mean ± SD. Bars, 2,000 µm.695 Astrocyte pVHL mediates vascular remodeling • Kurihara et al.
Figure 4.  HIF-1, but not HIF-2, regulates MIF in astrocytes. (A) Mif mRNA expression was monitored by real-time RT-PCR and plotted on a scatter 
plot at P3, 6, 9, 11, 14, 21, and 28 early postnatal stages of hyaloidal vessel regression in isolated retinas. Note that significant down-regulation is 
observed at P14 compared with P3 (n = 8). (B) Immunohistochemistry with MIF and GFAP antibodies in P14 retinal ganglion cell layer is shown. Note 
that MIF expression is colocalized with astrocytes in the ganglion cell layer. (C) Mif and F4/80 mRNA expression in Vhl/Hif-2 double mutants at 
P14. Note that the ectopic stabilization of HIF-1 in retinal astrocytes results in simultaneous (and significant) up-regulation of Mif and F4/80 (n = 4). 
KO, knockout. (D) Immunocytochemistry for MIF was performed on cultured C8-D1A murine astrocyte cells. Note that MIF is robustly expressed in the 
cytoplasm (visualized with phalloidin labeling) of C8-D1A cells (all cells are counterstained with DAPI). (E) Relative mRNA expression of Hif-1, Hif-2, 
Vegf, and Mif in C8-D1A cells transfected with CA–Hif-1, CA–Hif-2, or Gfp. Note that the transfection of CA–Hif-1 induces Hif-1 in C8-D1A (top 
left), and CA–Hif-2 induces robust Hif-2 expression (top right). Vegf is up-regulated significantly (4.9-fold; P = 0.00024) when C8-D1A cells are trans-
fected with CA–Hif-2. Mif is significantly (1.9-fold; P = 0.000057) up-regulated by CA–Hif-1 (n = 11–12). (F) VEGF and MIF-secreted protein levels 
were measured from supernatants of CA–Hif-1 or CA–Hif-2–transfected C8-D1A cells using quantitative sandwich ELISAs (n = 5–6). VEGF secretion 
is significantly (2.7-fold; P = 0.009) up-regulated by CA–Hif-2 (top). MIF is significantly (7.6-fold; P = 0.03) up-regulated by CA–Hif-1 (bottom).   
(G–J) Representative hyaloidal vasculature (G and I) and number of branching points (H and J) in HIF-1 (G and H) or HIF-2 (I and J) mutants are shown 
at P9 (n = 6). Note that in HIF-1 mutants, delayed hyaloidal regression compared with control littermate is observed in early postnatal stages. n.s., not 
significant. *, P < 0.05; **, P < 0.01. Error bars indicate mean ± SD. Bars: (B) 20 µm; (D) 50 µm; (G and I) 2,000 µm.JCB • VOLUME 195 • NUMBER 4 • 2011   696
(Fig. 5 H) and up-regulation of F4/80 (P = 0.016; Fig. 5 I), 
  demonstrating that, like Hif-1, MIF is sufficient to induce 
  macrophage-mediated vascular remodeling in the eye. Finally, we 
also treated a set of mice with three i.p. injections of a specific 
MIF antagonist, ISO-1 (35 mg/kg), or vehicle over 6 d starting 
at P8. This dosage has been shown to be effective in blocking   
lipopolysaccharide-induced sepsis in mice (Al-Abed et al., 2005). 
In  mice  treated  with  ISO-1,  significantly  more  branching   
points were observed than in vehicle-injected mice, suggesting 
that endogenous MIF regulates normal hyaloidal regression   
(P = 0.012; Fig. 5 J; quantified in Fig. 5 K). In another set of 
mice, ISO-1 was injected three times, 3 d and 1 d before and   
1 d after intravitreal astrocyte injection. No significant differ-
ences were observed between groups pretreated with ISO-1 and 
then injected with CA–Hif-1/GFP or GFP-transfected con-
trol astrocytes (P = 0.39; Fig. 5 L; quantified in Fig. 5 M),   
demonstrating that the MIF antagonist effectively neutralizes 
the CA–Hif-1/GFP–mediated accelerated regression. These 
findings support the concept that HIF-1/MIF signaling is   
necessary and sufficient to recruit circulating macrophages   
into the vitreous and regulate hyaloidal vessel regression.
Macrophage-derived MIF also acts to 
accelerate hyaloidal regression in an 
autocrine manner
Having  established  a  role  for  the  astrocyte-specific  pVHL/
HIF-1/MIF  pathway  in  the  regulation  of  hyaloidal  vascular 
growth and regression, we also investigated the role of this 
pathway in macrophages using conditional gene inactivation. 
pVHL was deleted in myeloid cell lineages (including macro-
phages) using M lysozyme (LysM)–Cre mice (Clausen et al., 
1999). In this line, significantly accelerated hyaloidal regres-
sion also was observed compared with control littermates   
(P = 0.0032; Fig. 6, A and B). RT-PCR analyses performed   
on  the  retinas  of  these  mice  revealed  up-regulation  of  Mif  
and F4/80 (P = 0.015 and 0.037, respectively; Fig. 6 C), sug-
gesting that even increases in autocrine-delivered MIF from 
macrophages themselves can promote the recruitment of addi-
tional migratory macrophages from the general circulation and 
accelerate the rate of hyaloidal vessel regression. Additionally, 
the conditional deletion of endogenous Vegf in myeloid cells does   
not induce any appreciable alteration of the rate of hyaloidal   
vessel regression (Fig. S5, G and H). Consequently, alterations   
to oxygen concentration in the eye may induce both astro-
cytes and macrophages to secrete MIF, which then recruits macro-
phages into the eye and regulates vascular remodeling.
Discussion
In this study, we used combinatorial conditional gain- and 
loss-of-function  assays  to  reveal  that  pVHL  in  astrocytes   
is necessary and sufficient for hyaloidal vessel regression. 
When Vhl is deleted, we observe two primary phenotypes:   
accelerated primary hyaloidal vascular regression and massive 
secondary outgrowth of hyaloidal vessels (Fig. 2). Our combi-
natorial  genetic  deletion  strategies  clearly  demonstrate  that 
VHL/HIF-2/VEGF signaling is responsible for inducing the 
To investigate the function of HIF-1 in physiological 
hyaloidal regression, we quantified the numbers of branching 
points of the hyaloidal vasculature in astrocyte-specific Hif-1 
or Hif-2 mutants at an early postnatal stage (P9) when Mif is 
expressed at significantly higher levels compared with a later 
stage, P14 (Fig. 4 A). In Hif-1 mutants, hyaloidal regression 
was  delayed  significantly  compared  with  control  littermates   
(P = 0.036; Fig. 4 G; quantified in Fig. 4 H), and no significant 
difference was observed in Hif-2 mutants and controls (Fig. 4, 
I and J). In later stages (P14) when Mif was normally down-
regulated (Fig. 4 A), no difference was observed between 
Hif-1 or Hif-2 mutants and controls (Fig. S5, C–F). These 
data confirm that HIF-1 is required for physiological hya-
loidal regression and for regulating Mif expression in astro-
cytes during hypoxic early postnatal stages.
The intravitreal injection of recombinant MIF 
or astrocytes transfected with CA–Hif-1 
accelerates hyaloidal vessel regression
To determine whether HIF-1/MIF signaling is sufficient to   
accelerate hyaloidal vessel regression, we examined the con-
tribution  of  each  factor  in  vivo  using  overexpression  and   
hyperactivation assays. We assessed the role of astrocytes 
overexpressing  HIF-1  by  transplanting  C8-D1A  cells  trans-
fected with CA–Hif-1/Gfp or Gfp alone. After transfection 
in  vitro,  adherent  cells  were  released  from  temperature-
sensitive UpCell matrices (thus preserving their surface anti-
gens)  and  injected  intravitreally  into  P11  mouse  eyes. To 
monitor the transplanted GFP-transfected astrocytes, we used 
CSLO  (Fig.  5  A).  3  d  after  injection  with  CA–Hif-1/Gfp  
(or only Gfp)–transfected C8-D1A cells, the hyaloidal vascula-
ture was examined in vivo using ICG angiography (Fig. 5,   
B and C). We observed a significant reduction in the number   
of branching points (P = 0.0020; Fig. 5 C) in eyes injected   
with CA–Hif-1/Gfp compared with those injected with Gfp 
alone. We also injected equal numbers of CA–Hif-1–transfected 
cells (no Gfp) and untransfected cells as controls in eyes of   
CX3CR1
GFP/+  transgenic  mice  in  which  myeloid  cells  are   
genetically labeled with GFP (Jung et al., 2000). Using CSLO,   
we observed a dramatic increase in the number of infiltrating 
GFP-positive  macrophages  in  eyes  injected  with  CA–Hif-1–
transfected astrocytes compared with controls (Fig. 5 D). Fur-
thermore, RT-PCR analyses with F4/80 probes performed in 
lysates  from  retinas  injected  with  CA–Hif-1–transfected   
astrocytes reveal a significant up-regulation (P = 0.049; Fig. 5 E). 
There is a concomitant increase in the number of recruited 
macrophages, which may explain how hyaloidal vessel regres-
sion was accelerated in Vhl mutants.
To determine whether MIF alone is sufficient to promote 
macrophage infiltration and hyaloidal vessel regression, we in-
jected recombinant murine MIF (rmMIF) into wild-type mouse 
eyes. We observed a dose-dependent, significant reduction of 
hyaloidal  vascular  branching  points  in  rmMIF-injected  eyes 
compared with vehicle-injected eyes (P = 0.060 and 0.00042 
for 1,000 and 100 ng of rmMIF, respectively; Fig. 5 F; quantified 
in Fig. 5 G). Furthermore, the injection of recombinant rmMIF 
also induced GFP-positive cell infiltration in CX3CR1
GFP/+ mice 697 Astrocyte pVHL mediates vascular remodeling • Kurihara et al.
Figure 5.  HIF-1/MIF signaling in astrocytes is sufficient in vivo to regulate macrophage accumulation and hyaloidal vessel regression. (A) Gfp-transfected 
C8-D1A cells (green) were transplanted into the vitreous space and visualized with ICG-infused hyaloidal vasculature (red) by CSLO in vivo. IR, infrared images 
(white). (B and C) Representative hyaloidal vascular images (B) and numbers of branching points (C) at P14 3 d after transplantation of Gfp or CA–Hif-1/Gfp–
transfected C8-D1A cells (n = 6–11). Note that the numbers of hyaloidal vessels are significantly reduced in eyes injected with CA–Hif-1/Gfp–transfected 
C8-D1A cells compared with Gfp only–transfected cells. (D) Representative images of GFP fluorescence from myeloid cells in CX3CR1
GFP/+ mice 3 d after 
transplantation of untransfected or Hif-1–transfected C8-D1A cells. Note that increased macrophage accumulation after transplantation of Hif-1–transfected 
cells is confirmed in the transgenic mice. (E) Relative F4/80 mRNA expression detected by real-time RT-PCR (n = 4). Significant up-regulation of F4/80 was 
observed in retinal/vitreal lysates after transplantation with CA–Hif-1/Gfp–transfected astrocytes compared with Gfp-transfected controls. (F and G) Represen-
tative hyaloidal vascular images (F) and numbers of branching points (G) at P14 3 d after injection of rmMIF. Note that injection of rmMIF induces accelerated 
hyaloidal regression significantly (1,000 ng of rmMIF; MIF 1000) compared with PBS (vehicle)-injected eyes. (H) Representative images of GFP signaling in   
CX3CR1
GFP/+ mice 3 d after 1,000 ng of rmMIF. (I) Real-time RT-PCR detected significant up-regulation of F4/80 with MIF injection compared with vehicle (n = 4).   
(J–M) Representative hyaloidal vascular images (J and L) and numbers of branching points (K and M) at P14 after i.p. injection of an MIF inhibitor, ISO-1, at P8, 
10, and 12 with (L and M) or without (J and K) transplantation of Gfp or CA–Hif-1/Gfp–transfected C8-D1A cells at P11 (n = 4–6). Note that injection of ISO-1   
slows the rate of hyaloidal vessel regression significantly (K). Pretreating mice with ISO-1 rescues the accelerated regression phenotype induced by injecting 
CA–Hif-1–transfected astrocytes at the same stage (M). n.s., not significant. *, P < 0.05; **, P < 0.01. Error bars indicate mean ± SD. Bars, 2,000 µm.JCB • VOLUME 195 • NUMBER 4 • 2011   698
models and strongly suggest that failure of oxygen sensing in 
astrocytes induces a PHPV-like picture as a result of an imbal-
ance of the divergent functions of HIF-1 and HIF-2. This 
may explain why the hyaloidal vessels regress at distinct time 
points in humans and rodents (the third trimester in utero and 
early postnatal stages, respectively), as hyaloidal vascular re-
gression occurs simultaneously with development of the retinal 
vascular networks in both systems.
Vhl mutants share several ocular phenotypic characteris-
tics with human PHPV (Reese, 1955; Goldberg, 1997). Human 
PHPV is clinically classified according to three types—anterior, 
posterior, and mixed—based on where the persistent vessels   
are observed. The massive secondary outgrowth (commonly   
referred  to  as  a  retrolental  mass  characteristic  of  anterior   
PHPV) extends from the central stalk (characteristic of posterior 
PHPV). Thus, the vascular network of the secondary outgrowth 
observed  in  Vhl  mutants  is  typical  of  human  mixed  PHPV   
(Fig. 2). Other transgenic mouse models (i.e., mutations to 
p19
Arf, Norrin, Fz4, and Angiopoietin-2) also share some fea-
tures of PHPV (Hackett et al., 2002; McKeller et al., 2002; 
Xu et al., 2004). However, defective retinal vascularization 
is also observed in some of these models, suggesting that   
the persistent hyaloidal vessels may be preserved to compen-
sate for retinal hypo- or avascularity. In contrast, astrocyte Vhl 
mutant mice have highly vascularized retinas (Fig. S3) and, 
thus, more closely resemble that observed in human PHPV. 
Although  the  density  of  astrocytes  is  also  increased  in  Vhl  
mutants (Fig. S4), we argue that this phenomenon alone cannot   
induce the PHPV-like phenotype. Data from multiple in vivo 
and in vitro assays more strongly suggest that the phenotype   
is induced by intrinsically modulating the HIF-1/MIF and 
HIF-2/VEGF pathways (Figs. 3–5). The progression of human 
PHPV is difficult to monitor, as it occurs in utero but currently 
is widely accepted to be a failure of hyaloidal vessel regression. 
Surprisingly and importantly, the current model presented in 
this study suggests that PHPV in humans may not be caused by 
incomplete primary regression but rather aberrant secondary 
angiogenesis, as revealed using novel in vivo vascular monitor-
ing techniques and daily observations (Fig. 2).
The observations made in our study may have applica-
tions for understanding the mechanisms involved in replacing 
secondary hyaloidal outgrowth (Fig. 3). Previous studies have 
shown that although HIF-1 is expressed in astrocytes, its 
function was unknown (Weidemann et al., 2009, 2010). In this   
study, we observe that HIF-1 in astrocytes functions to regu-
late hyaloidal vascular regression by inducing the production   
of MIF, which leads to the recruitment of macrophages critical 
to the vascular remodeling associated with the shift in the   
retina from embryonic to adult vasculature (Figs. 4 and 5). 
Finally, we demonstrate that both paracrine- and autocrine-
derived MIF is required to regulate hyaloidal regression (Fig. 6). 
From these observations, we conclude that careful regulation of 
divergent HIF-1 and HIF-2 functions is critical, as ectopic 
stabilization leads to significant ocular vascular abnormali-
ties (Fig. 7).
We demonstrate a previously unreported role for HIF-1 
in vascular remodeling: regulating MIF expression and macro-
phage infiltration in vivo. Although not all cells express both 
HIF-1 and HIF-2, in those that do (i.e., epidermal cells, he-
patocytes, intestinal epithelium cells, and astrocytes), HIF-2 
tends to function in a dominant manner (Rankin et al., 2007, 
2008;  Boutin  et  al.,  2008;  Mastrogiannaki  et  al.,  2009; 
  Weidemann et al., 2009). Although HIF-2 alone does mediate 
accelerated  regression  in  Vhl  mutants  through  an  unknown 
mechanism that merits future study (Fig. 3 D), we do show that 
HIF-1 has an important role not only during abnormal accel-
erated regression but also during physiological regression (Fig. 4, 
G and H). These observations, describing differential and   
essential roles of HIF-1 and HIF-2 in astrocytes, reveal   
a novel mechanism of pathological vascular remodeling.
In  utero,  physiological  hypoxia  is  required  for  normal   
development in various tissues. Previous studies (Chen et al., 
2008; Kurihara et al., 2010), as well as this study, have shown 
that changes in oxygen availability may drive pVHL-dependent 
degradation of HIF-s and initiate ablation and clearance of   
the fetal vasculature. In humans, growth of the retinal vascular 
network and regression of the hyaloidal vessels start in the 
third trimester. An oxygen-sensing role for astrocytes has been 
proposed in the central nervous system (Bernaudin et al., 2000) 
and may exhibit a similar role in the retina, where these cells   
can  also  influence  the  developing  retinal  vasculature  (West   
et al., 2005). The data presented in this study support these 
Figure 6.  Myeloid cell–specific Vhl deletion induces accelerated 
hyaloidal vascular regression. (A and B) Representative images 
of hyaloidal vasculature (A) and numbers of branching points (B) 
in myeloid cell–specific Vhl;Lysm-Cre mutant mice (n = 4–6). Note 
that significantly accelerated hyaloidal regression was observed 
in macrophage Vhl mutants at P16. KO, knockout. Bar, 2,000 µm. 
(C) Quantitative RT-PCR for Mif and F4/80 in macrophage Vhl 
mutants (n = 4). Note that Mif and F4/80 are significantly up-
regulated in mutants compared with controls, suggesting that 
autocrine MIF secretion from macrophages causes tissue infiltra-
tion of macrophages that mediate the accelerated regression.   
*, P < 0.05. Error bars indicate mean ± SD.699 Astrocyte pVHL mediates vascular remodeling • Kurihara et al.
Immunofluorescence
Whole-mount  preparations  were  performed  as  previously  described 
  (Weidemann et al., 2010). In brief, retinae were fixed in 4% PFA for 1 h.   
After blocking with 10% FBS (Invitrogen) and 10% normal goat serum   
(The Jackson Laboratory) in PBS for 1 h, retinae were incubated with   
the primary antibodies described below, washed, and incubated with   
the fluorescence-conjugated secondary antibody (1:200 dilution; Invitro-
gen). Retinae were then laid flat with four radial relaxing incisions and 
mounted for whole-mount image capturing using confocal microscopy. For 
immunohistochemistry,  eyes  were  enucleated  after  euthanasia,  fixed  in   
ice-cold 4% PFA (Electron Microscopy Sciences), and embedded in OCT 
compound (Sakura). For immunocytochemistry, cells grown in chambered 
slides (Lab-Tek II; Nalge Nunc International) were briefly fixed in room   
temperature 4% PFA. Tissues and cells were briefly permeabilized with 1.0 
or 0.5% Triton X-100 (Sigma-Aldrich), respectively, before blocking with 
2% normal goat serum solution (Jackson ImmunoResearch Laboratories, 
Inc.). 2-h room temperature incubations were performed with all primary 
antibodies. After washing with PBS, secondary antibodies (Alexa Fluor 
488, 568 or 594, and 647; Invitrogen) diluted 1:1,000 were added for 
30 min. Cells were counterstained with DAPI (Invitrogen) and washed   
before mounting. The following primary antibodies were used in this   
study: chicken polyclonal GFAP (1:2,000; Abcam), rabbit polyclonal   
GFAP  (1:1,000;  Invitrogen),  rabbit  polyclonal  MIF  (1:50;  Santa  Cruz   
Biotechnology, Inc.), rabbit polyclonal GFP (1:100; Abcam), and fluorescent- 
conjugated phalloidin (1:2,000). Fluorescent-conjugated isolectin Griffonia 
Simplicifolia IB-4 was also used (GS-lectin; Invitrogen). Imaging was per-
formed in a mounting medium (SlowFade gold antifade reagent; Invitrogen) 
at room temperature on a confocal microscope (LSM 710; Carl Zeiss) with   
an EC Plan-Neofluar 10×/0.30, Plan-Apochromat 20×/0.80, or Plan-
Apochromat 40×/0.95 objective lens (Carl Zeiss). All images are pro-
cessed with ZEN 2010 software.
RT-PCR analysis
Total RNA was prepared from vitreo-retinal tissues using the RNeasy 
Plus Mini kit (QIAGEN) and was reverse transcribed using Superscript II 
(Invitrogen). Quantitative PCR assays were performed on a real-time 
PCR System (ABI 7900HT Fast) using a PCR master mix (TaqMan Fast 
Universal;  Applied  Biosystems)  and  TaqMan  gene  expression  assay   
mix of hif-1a (Mm00468869_m1), hif-2a (Mm00438717_m1), vegfa 
(Mm00437304_m1), mif (Mm01611157_gH), and f4/80 (Mm00802530_m1).   
Eukaryotic 18S ribosomal RNA TaqMan minor groove binder probe 
was used as an endogenous control. Data were analyzed with 7900HT 
Fast System SDS software (version 2.4; Applied Biosystems). All experi-
ments were performed with four replicates.
ELISA
We measured murine MIF and murine VEGF expression levels using 
colorimetric  quantitative  sandwich  ELISA  kits  (R&D  Systems  or  Kamiya   
Biomedical Company, respectively). 2 d after transfection, 2 mL of media 
was removed from cells grown in 6-well plates and concentrated using 
centrifugal filters (Amicon Ultra 10K; Millipore). Each condition was tested   
in triplicate according to the manufacturer’s specifications, and the out-
put was measured using a microplate reader (Synergy 2; BioTek). Concen-
trations were obtained by fitting the data to a standard curve using 
nonlinear four-factor regression.
embryonic with adult vasculature in other tissues (i.e., cardiac, 
pulmonary, or umbilical systems). Macrophage recruitment 
by MIF may promote key remodeling events to initiate vascular   
remodeling and regeneration of diseased tissues. It may also   
be possible to use recombinant MIF as a tool to modulate   
tumor vasculature. Furthermore, therapies targeting HIF-1 
and HIF-2 in astrocytes or macrophages using specific an-
tagonists may also prove to be effective modulators of patho-
logical angiogenesis in multiple tissues.
Materials and methods
Mice
All procedures involving animals were approved by the Scripps Research 
Institute Animal Care Committee, which ensures that all federal guidelines 
concerning animal experimentation are met. Transgenic mice expressing 
Cre recombinase under GFAP (GFAP-Cre mice; Bajenaru et al., 2002) or 
LysM promoter (LysM-Cre mice; Clausen et al., 1999) were mated with 
Vhl
floxed/floxed (Haase et al., 2001), Hif-1
floxed/floxed (Ryan et al., 2000), or 
Hif-2
floxed/floxed (Gruber et al., 2007) or Vegf
floxed/floxed mice (Gerber et al., 
1999). As control littermates, floxed mice without Cre transgene were 
used. To monitor Cre recombination in GFAP-Cre mice in astrocytes, we 
mated them with ROSA26 (reverse orientation splice acceptor 26) mTomato/
mGFP transgenic reporter mice (Muzumdar et al., 2007). To monitor myeloid 
cells in vivo, CX3CR1
GFP/+ mice (Jung et al., 2000) were used.
Vascular corrosion casting
Plastic resin was prepared using a vasQtec kit according to the manufac-
turer’s instructions. Green fluorescent pigment (vasQtec) was added to the 
resin  to  improve  visualization  for  imaging.  Mice  were  slowly  perfused   
using published protocols with a cerebral spinal fluid–like solution followed 
by 2% formalin (Sigma-Aldrich) in PBS and then followed by the resin 
(Krucker et al., 2006). After the perfusion, the plastic hardened for at least 
5 d before the soft tissues were dissolved with 7.5% KOH (Sigma-Aldrich) 
at 50°C overnight. The casts were decalcified in 2.5% formic acid (Sigma-
Aldrich) for 12 h at 50°C. The casts were imaged in PBS at room tempera-
ture on an upright confocal microscope (LSM 510; Carl Zeiss) with a 5× 
objective lens (EC Plan-Neofluar 5×/0.16; Carl Zeiss). 3D reconstructions 
were generated using ZEN 2010 software (Carl Zeiss).
In vivo hyaloidal vasculature imaging
To monitor hyaloidal regression in vivo, we used CSLO (SPECTRALIS;   
Heidelberg Engineering). Mice were anesthetized by an i.p. injection   
of 15 mg/kg ketamine and 7 mg/kg xylazine, and ICG (50 µg/g body 
weight) was injected intraperitoneally. Pupils were dilated immediately be-
fore imaging with 1% tropicamide and 2.5% phenylephrine. To quantify 
the numbers of the branching points, images were obtained by five differ-
ent angles from each animal. Branching points were manually counted. 
The branching points in the central vasculature were counted first, and then   
the peripheral branches were counted. Peripheral branching points were 
only counted when they did not appear in the center image (Fig. S1).
Figure  7.  Current  hypothetical  model  for 
pVHL-controlled  hyaloidal  vascular  remodel-
ing.  (A)  Hyaloidal  vasculature  regression  is 
directed  by  the  oxygen-sensing  pVHL/HIF 
pathway in astrocytes to regulate the flux of   
infiltrating macrophages. In Hif-1 mutants, Mif 
levels are attenuated, fewer macrophages are 
recruited into the vitreous, and hyaloidal vas-
culature regression is retarded. In Vhl mutants, 
MIF levels increase dramatically as a result of 
HIF-1 stabilization; this results in accelerated 
hyaloidal vasculature regression. Increases in 
VEGF secretion as a result of HIF-2 stabiliza-
tion stabilize the stalk of the hyaloidal network 
and  induce  secondary  outgrowth  of  vessels 
along a superficial plane. (B) Astrocytes sense 
fluctuations in oxygen concentrations in the retina and respond by suppressing pVHL. This in turn stabilizes HIF-1 and HIF-2 that regulate MIF and VEGF, 
respectively. HIF-1/MIF signaling regulates macrophage recruitment and controls the rate of hyaloidal vessel regression. Conversely, HIF-2/VEGF signal-
ing induces pathological neovascularization of hyaloidal vessels when dysregulated.JCB • VOLUME 195 • NUMBER 4 • 2011   700
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The  mouse  astrocyte  C8-D1A  line  was  obtained  from  American  Type   
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with GlutaMax (Invitrogen) and 10% FBS (Invitrogen). C8-D1A cells were   
transfected using Attractene (QIAGEN) using a total DNA/Attractene ratio   
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